سعر لوسنبلاج شراب 125 مل 2025

Lusenplug syrup (125 ml) by Badr Pharma (Egypt): a cough and cold combination of dextromethorphan (cough suppressant), guaifenesin (expectorant) and phenylephrine (nasal decongestant).

• Temporary relief of nasal congestion and cough associated with acute respiratory tract infections, such as the common cold and related conditions (e.g. sinusitis, acute bronchitis).Population: Adults and children 6 years and olderBadr Pharma
• Temporarily relieves common cold symptoms: stuffy nose, nasal congestion, cough due to minor throat and bronchial irritation; helps loosen phlegm and thin bronchial secretions.Population: ChildrenDailyMed (U.S. National Library of Medicine)

• Mild (1-10%): drowsiness, headache, fatigue, nausea; also restlessness, anxiety, dizziness, tremor, insomnia, rash. Severe (incidence not known): intracranial bleeding, stroke, arrhythmia, ventricular tachycardia, seizures, serotonin syndrome, anaphylactoid reactions.Per the manufacturer · Badr Pharma

• Severe or uncontrolled hypertension and peripheral vascular disease (phenylephrine).Per the manufacturer · Badr Pharma
• Urinary retention (phenylephrine-containing products).Per the manufacturer · Badr Pharma
• Patients receiving monoamine oxidase inhibitor (MAOI) therapy and for 14 days after stopping MAOI therapy.Per the manufacturer · Badr Pharma

• Not for persistent or chronic cough such as occurs with smoking, asthma, emphysema or chronic bronchitis, or cough with excessive secretions, unless supervised by a health care professional.Per the manufacturer · Badr Pharma
• Not recommended in children under 6 years of age.Per the manufacturer · Badr Pharma
• Relatively contraindicated or use with caution in cardiac disease (including arrhythmias and cardiomyopathy), cerebrovascular disease, coronary artery disease, diabetes mellitus, hyperthyroidism, prostatic hypertrophy or bladder obstruction, and hepatic disease.Per the manufacturer · Badr Pharma

• MAOIs (isocarboxazid, phenelzine, selegiline, tranylcypromine, rasagiline)Contraindicated: risk of serotonin syndrome with dextromethorphan and hypertensive reactions with phenylephrine; do not use during and for 14 days after MAOI therapy.Badr Pharma
• Serotonergic drugs (e.g. fluoxetine, paroxetine, linezolid)Use with caution because of the risk of serotonin syndrome with dextromethorphan.Badr Pharma
• Pulmonary arterial hypertension drugs (bosentan, macitentan, epoprostenol, iloprost, treprostinil, selexipag, riociguat)Avoid use of sympathomimetic agents such as phenylephrine.Badr Pharma

• Safe use in pregnancy has not been established; systemic phenylephrine is generally avoided because of vasoconstrictive effects; use only if potential benefits outweigh risks. In late pregnancy or labour phenylephrine can cause fetal anoxia and/or bradycardia.Per the manufacturer · Badr Pharma
• Not known whether the ingredients are excreted in breast milk; give cautiously to breastfeeding women and decide whether to discontinue breastfeeding or the product.Per the manufacturer · Badr Pharma

English text not available for this section.

Store at a temperature not exceeding 30°C.